Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Rania Abusamra (London, United Kingdom), Rania Abusamra, Sarah Latham, Shrabani Chakraborty, Marc Woodman, Cara Bossley, Gary Ruiz, Atul Gupta. Real life experience of omalizumab on selected children with severe allergic asthma. Eur Respir J 2016; 48: Suppl. 60, 1238

Member's Comments

No comment yet.

Related content which might interest you: Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study Source: International Congress 2016 – Asthma points to ponder Year: 2016 Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab Source: International Congress 2014 – More paediatric asthma Year: 2014 One year following a real life experience of omalizumab for moderate to severe persistent allergic asthma in Malta Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 The effect of SLIT on asthma symptoms at different pediatric age ranges Source: Annual Congress 2013 –Treatment of asthma Year: 2013 FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Predicting asthma exacerbations in children – A real life observational study Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia Year: 2015 Real life effectiveness of omalizumab in severe allergic asthma, does the IgE level matter? A Bradford experience Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 First clinical trial of a new IgE-adsorber in allergic asthma Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma Year: 2015 Sensitization to moulds in patients with newly diagnosed allergic asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Allergic disorders in relation to asthma and spastic bronchitis in children Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Risk factors for poor asthma control in asthmatic children Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Phenotypes of asthma in mothers have an influence on asthma phenotypes in children Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016 Safety of tiotropium in pre-school children with symptomatic persistent asthma Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016 The impact of psychological distress on allergic rhinitis and asthma control Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015